Baxter International Inc.

RSS Feed
Baxter International, through its subsidiaries, provides a portfolio of healthcare products, including acute and chronic dialysis therapies; sterile intravenous solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. These products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision. The company manages its business based on three geographic segments: Americas (North and South America), Europe, Middle East and Africa and Asia-Pacific.
  • TickerBAX
  • ISINUS0718131099
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States
MarketLine
MarketLine Department

Fresenius SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report

Summary Fresenius SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Fresenius SE & Co. KGaA (Fresenius or 'the group'), the holding company of the Fresenius Group, is a leading global provider of products and services for dialysis, hospitals and outpatient medical care. Its major products and services include solutions for infusion therapy; machines ...

EUR 144.87
Equity
Health Care
BAX , DVA ...
48d 29/11/2020 49 EN
MarketLine
MarketLine Department

Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

Summary Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Alexion Pharmaceuticals, Inc. (Alexion or 'the company') is a biopharmaceutical company involved in the innovation, development and commercialization of life-transforming therapeutic products. The company focuses on the therapeutic areas such as Neurology, Hematology, Nephrolog...

EUR 144.87
Equity
Health Care
AMGN , BAX ...
48d 29/11/2020 52 EN
MarketLine
MarketLine Department

Integra LifeSciences Holdings Corporation - Strategy, SWOT and Corporate Finance Report

Summary Integra LifeSciences Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Integra LifeSciences Holdings Corporation (Integra or 'the company') is a provider of medical technology solution. The company offers regenerative technologies, surgical solutions, and orthopedics and tissue technologies. Its products find application in burn and ti...

EUR 144.87
Equity
Health Care
BAX , GMED ...
48d 29/11/2020 57 EN
MarketLine
MarketLine Department

Bayer AG - Strategy, SWOT and Corporate Finance Report

Summary Bayer AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Bayer AG (Bayer or 'the group') is a life science company that develops pharmaceutical, and chemical products. The company offers prescription and non-prescription medical products, cosmetics, seeds, plant traits, chemical, biological crop protection products. It also offers products and solutions ...

EUR 144.87
Equity
Health Care
ABT , AZN ...
48d 29/11/2020 72 EN
MarketLine
MarketLine Department

Boston Scientific Corporation - Strategy, SWOT and Corporate Finance Report

Summary Boston Scientific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Boston Scientific Corporation (Boston Scientific) is a manufacturer of medical devices used in interventional medical specialties. The company's solutions include drug-eluting coronary stent systems, percutaneous coronary interventions (PCI), intravascular catheter-directed ult...

EUR 144.87
Equity
Health Care
ABT , ATRI ...
48d 29/11/2020 70 EN
Vermilion Research
Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

EUR 41.39
Chart
Construction & Materials
AOS , ANF ...
1y 01/04/2019 19 EN
SmartInsider

Baxter International Inc: 1 director sold

A director at Baxter International Inc sold 3,742 shares at 91.000USD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names...

EUR 8.28
Corporate Voice
Health Care
Baxter International Inc.
225d 05/06/2020 1 EN
BusinessWire

Baxter Declares Dividend and Announces Quarterly Dividend Increase

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX) today announced an approximately 19% increase in the company’s quarterly dividend rate. This rate increase was made in connection with the declaration of a quarterly cash dividend of $0.19 per share of common stock (up from $0.16 per share), payable on July 2, 2018, to stockholders of record as of June 1, 2018. The indicated annual dividend rate is now $0.76 per share of common stock. “Baxter is pleased to raise our quarterly dividend rate,” said José ...

Free
Corporate Voice
Health Care
Baxter International Inc.
2y 08/05/2018 1 EN
BusinessWire

Baxter and the International Society of Nephrology Announce a Collaboration to Address Growing Prevalence of Kidney Disease

DEERFIELD, Ill. & BRUSSELS--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), a global innovator in renal (kidney) care, and the International Society of Nephrology (ISN) announced a partnership to advance chronic kidney disease (CKD) awareness and help improve access to therapy, particularly in low- and middle-income countries (LMIC) – commonly referenced as emerging markets – where the disease prevalence is growing the fastest. The collaboration will support greater disease and therapy research and education, as well as ...

Free
Corporate Voice
Health Care
Baxter International Inc.
2y 02/05/2018 1 EN
BusinessWire

Baxter Reports First-Quarter 2018 Results and Increases Financial Outlook for Full-Year 2018

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX) today reported results for the first quarter of 2018 and increased its full-year 2018 guidance. “Baxter is off to a strong start in 2018,” said José (Joe) E. Almeida, chairman and chief executive officer. “Solid top-line performance coupled with a relentless focus on increasing operational efficiency were key drivers of earnings growth in the quarter. We look forward to building on this momentum and sharing the next chapter in Baxter’s ongoing transforma...

Free
Corporate Voice
Health Care
Baxter International Inc.
2y 26/04/2018 1 EN
BusinessWire

Baxter to Host First Quarter 2018 Financial Results Conference Call for Investors

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), will host a conference call to discuss its first quarter 2018 financial results on Thursday, April 26, 2018, at 7:30 a.m. Central Daylight Time. To access the call, dial 844-886-1929 (domestic) or 225-239-4663 (international). Please dial into the call at least 10 minutes prior to the start for the operator to connect you. The Conference ID is 9881128. This call is also being webcast by Nasdaq OMX and can be accessed at Baxter’s website at www....

Free
Corporate Voice
Health Care
Baxter International Inc.
2y 04/04/2018 1 EN
MarketLine
MarketLine Department

Fresenius SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report

Summary Fresenius SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Fresenius SE & Co. KGaA (Fresenius or 'the group'), the holding company of the Fresenius Group, is a leading global provider of products and services for dialysis, hospitals and outpatient medical care. Its major products and services include solutions for infusion therapy; machines ...

EUR 144.87
Equity
Health Care
BAX , DVA ...
48d 29/11/2020 49 EN
MarketLine
MarketLine Department

Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

Summary Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Alexion Pharmaceuticals, Inc. (Alexion or 'the company') is a biopharmaceutical company involved in the innovation, development and commercialization of life-transforming therapeutic products. The company focuses on the therapeutic areas such as Neurology, Hematology, Nephrolog...

EUR 144.87
Equity
Health Care
AMGN , BAX ...
48d 29/11/2020 52 EN
MarketLine
MarketLine Department

Integra LifeSciences Holdings Corporation - Strategy, SWOT and Corporate Finance Report

Summary Integra LifeSciences Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Integra LifeSciences Holdings Corporation (Integra or 'the company') is a provider of medical technology solution. The company offers regenerative technologies, surgical solutions, and orthopedics and tissue technologies. Its products find application in burn and ti...

EUR 144.87
Equity
Health Care
BAX , GMED ...
48d 29/11/2020 57 EN
MarketLine
MarketLine Department

Bayer AG - Strategy, SWOT and Corporate Finance Report

Summary Bayer AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Bayer AG (Bayer or 'the group') is a life science company that develops pharmaceutical, and chemical products. The company offers prescription and non-prescription medical products, cosmetics, seeds, plant traits, chemical, biological crop protection products. It also offers products and solutions ...

EUR 144.87
Equity
Health Care
ABT , AZN ...
48d 29/11/2020 72 EN
MarketLine
MarketLine Department

Boston Scientific Corporation - Strategy, SWOT and Corporate Finance Report

Summary Boston Scientific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Boston Scientific Corporation (Boston Scientific) is a manufacturer of medical devices used in interventional medical specialties. The company's solutions include drug-eluting coronary stent systems, percutaneous coronary interventions (PCI), intravascular catheter-directed ult...

EUR 144.87
Equity
Health Care
ABT , ATRI ...
48d 29/11/2020 70 EN
Moody's Investors Service

Baxter International Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

EUR 620.85
Fixed Income
Health Care
Baxter International Inc.
59d 19/11/2020 1 EN
Moody's Investors Service

Moody's assigns Baa1 rating to Baxter's senior unsecured notes

Rating Action: Moody's assigns Baa1 rating to Baxter's senior unsecured notes. Global Credit Research- 29 Oct 2020. New York, October 29, 2020-- Moody's Investors Service, assigned a Baa1 rating to Baxter International Inc.' s senior unsecured notes.

EUR 149.00
Fixed Income
Health Care
Baxter International Inc.
80d 29/10/2020 5 EN
Moody's Investors Service

Baxter International Inc. - June 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

EUR 620.85
Fixed Income
Health Care
Baxter International Inc.
151d 19/08/2020 2 EN
Moody's Investors Service

Moody's announces completion of a periodic review of ratings of Baxter International Inc.

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Baxter International Inc.. Global Credit Research- 20 May 2020. New York, May 20, 2020-- Moody's Investors Service has completed a periodic review of the ratings of Baxter International Inc. and other ratings that are associated with the same analytical unit.

Fixed Income
Health Care
Baxter International Inc.
242d 20/05/2020 4 EN
Moody's Investors Service

Baxter International Inc. - March 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

EUR 620.85
Fixed Income
Health Care
Baxter International Inc.
244d 18/05/2020 2 EN
Ford Equity Research

Ford Equity US Rating and Forecast Report

Ford Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.

EUR 18.48
Quant
Health Care
Baxter International Inc.
4y 16/12/2016 3 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch